The dynamics of the germ cell tumors market are anticipated to change in the coming years owing to the approval of ...

Title: GOBLET platform study: Preliminary safety and tumor response results for the relapsed anal carcinoma cohort in patients treated with pelareorep and atezolizumab. Session Title: Poster Session C ...

AnaptysBio's rosnilimab faces significant competition and uncertainty. See why ANAB stock's future hinges on Feb 2025 Phase ...

It was a busy week in the biotech sector with lots of regulatory and pipeline updates. Among bigwigs, Gilead Sciences, Inc.

A recent report from MarketsAndMarkets projected that the global gastric cancer market accounted for USD 3.01 billion in 2023 and is expected to reach USD 18.43 billion by 2034 with a CAGR of 17.92% ...

The global cervical dysplasia treatment market is poised for steady growth, with a projected valuation of US$ 846.2 million ...

Broad enrollment criteria appear to have scuttled the trial, which was designed to test whether ctDNA could identify patients ...

China is the fourth major market where Kisunla has been approved after the US, Japan, and GB. It gets the green light there ...

Independent Analysis of Annual Sales Forecasts by Distribution Channel (Retail Pharmacies, Online Pharmacies, Other ...

The meningococcal B vaccine Bexsero is funded for people aged 13-25 who are entering their first year of close-living ...

The global opioid use disorder treatment market is poised for significant growth, with an expected market size of USD 3.07 ...

The Global Cancer Vaccines Market is experiencing a significant growth phase, with its valuation rising from $4,188 million in 2019 to an expected $7,303 million by 2027. This report aims to provide a ...